ATE422547T1 - Verfahren zur heterologen expression sekundärer metabolite - Google Patents

Verfahren zur heterologen expression sekundärer metabolite

Info

Publication number
ATE422547T1
ATE422547T1 AT05810933T AT05810933T ATE422547T1 AT E422547 T1 ATE422547 T1 AT E422547T1 AT 05810933 T AT05810933 T AT 05810933T AT 05810933 T AT05810933 T AT 05810933T AT E422547 T1 ATE422547 T1 AT E422547T1
Authority
AT
Austria
Prior art keywords
expression
heterologue
secondary metabolites
heterologous
myxochromide
Prior art date
Application number
AT05810933T
Other languages
German (de)
English (en)
Inventor
Youming Zhang
Rolf Mueller
Francis Stewart
Frank Gross
Silke Wenzel
Jun Fu
Original Assignee
Gene Bridges Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Bridges Gmbh filed Critical Gene Bridges Gmbh
Application granted granted Critical
Publication of ATE422547T1 publication Critical patent/ATE422547T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT05810933T 2004-10-26 2005-10-26 Verfahren zur heterologen expression sekundärer metabolite ATE422547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0423755.8A GB0423755D0 (en) 2004-10-26 2004-10-26 Methods for heterologus expression of secondary metabolites

Publications (1)

Publication Number Publication Date
ATE422547T1 true ATE422547T1 (de) 2009-02-15

Family

ID=33485231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810933T ATE422547T1 (de) 2004-10-26 2005-10-26 Verfahren zur heterologen expression sekundärer metabolite

Country Status (9)

Country Link
US (1) US20090298117A1 (enExample)
EP (1) EP1809749B1 (enExample)
JP (1) JP5566577B2 (enExample)
AT (1) ATE422547T1 (enExample)
AU (1) AU2005298341B2 (enExample)
CA (1) CA2584777A1 (enExample)
DE (1) DE602005012718D1 (enExample)
GB (1) GB0423755D0 (enExample)
WO (1) WO2006046152A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0605166A (pt) * 2006-11-03 2008-07-01 Inst Fleury método de determinação de ácido metilmalÈnico baseado na extração alquilativa associada à cromatografia lìquida acoplada à espectrometria de massas
GB0922108D0 (en) 2009-12-17 2010-02-03 Gene Bridges Gmbh Heterologous hosts
EP3027754B1 (en) 2013-08-02 2022-03-02 enEvolv, Inc. Processes and host cells for genome, pathway, and biomolecular engineering
WO2017151059A1 (en) * 2016-02-29 2017-09-08 Agency For Science, Technology And Research Multiplexable activation of silent biosynthetic clusters in native actinomycete hosts for natural product discovery
EP3938518A4 (en) 2019-03-12 2023-01-11 Terra Bioworks, Inc. EXPRESSION VECTOR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291420B1 (en) * 1997-12-05 2009-11-25 Europäisches Laboratorium Für Molekularbiologie (Embl) Novel DNA cloning method relying on the E.coli RECE/RECT recombination system
US6355412B1 (en) * 1999-07-09 2002-03-12 The European Molecular Biology Laboratory Methods and compositions for directed cloning and subcloning using homologous recombination
JP2004508810A (ja) * 2000-04-28 2004-03-25 コーサン バイオサイエンシーズ, インコーポレイテッド ポリケチドの生成
WO2003044186A2 (en) * 2001-11-22 2003-05-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel gene cluster of pederin biosynthesis genes
US20040005672A1 (en) * 2002-02-22 2004-01-08 Santi Daniel V. Heterologous production of polyketides

Also Published As

Publication number Publication date
WO2006046152A2 (en) 2006-05-04
AU2005298341A1 (en) 2006-05-04
JP5566577B2 (ja) 2014-08-06
EP1809749A2 (en) 2007-07-25
EP1809749B1 (en) 2009-02-11
CA2584777A1 (en) 2006-05-04
US20090298117A1 (en) 2009-12-03
DE602005012718D1 (de) 2009-03-26
WO2006046152A3 (en) 2006-11-16
AU2005298341B2 (en) 2011-06-23
GB0423755D0 (en) 2004-11-24
JP2008517996A (ja) 2008-05-29

Similar Documents

Publication Publication Date Title
DK1658365T3 (da) Fremgangsmåde til genkloning af produktionsceller
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE60328844D1 (de) Verfahren zur Tonererstellung
NO20071309L (no) Fremgangsmate for ekspansjon
EP1849757A4 (en) METHOD FOR PRODUCING AN UNSATURATED HYDROCARBON CONNECTION
DE60306282D1 (de) Verfahren zur Datenkommunikation mittels Kontrollmitteilung
WO2009027614A3 (fr) Procede de dedoublement de sels de l'omeprazole
ATE515498T1 (de) Verfahren zur aufreinigung von montelukast und dessen aminsalzen
EP1601809A4 (en) PROCESS FOR PRODUCING BIPHASED TOLE
NO20066078L (no) Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon
ATE491789T1 (de) Verfahren zur herstellung gamma-carboxylierter proteine
DE502005003004D1 (de) Verfahren zur herstellung von polycarbonat
ATE422547T1 (de) Verfahren zur heterologen expression sekundärer metabolite
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
ZA200610470B (en) Novel sequence for improving expression of nucleic acid
DK1592817T3 (da) Fremgangsmåde til fremstilling af et hårdmetalemne
DK1749096T3 (da) Fremgangsmåde til fremstilling af egnede DNA-konstrukter til specifik inhibering af genekspression ved RNA-interferens
EA201071025A1 (ru) Способ получения [фенилсульфанилфенил]пиперидинов
DE502005003098D1 (de) Verfahren zur herstellung von polycarbonat
ATE521596T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
FR2854402A1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
AU2003304144A8 (en) Intracellular production of specific rna molecules by splicing
DE602005011294D1 (de) Verbessertes verfahren zur herstellung von mirtazapin
DE50309640D1 (de) Verfahren zur verrottung von müll mittels einer adsordierenden plane

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties